350 µg Dexamethasone [clinicaltrials_resource:NCT00168298/group/O2]
350 µg Dexamethasone intravitreal implant administered on Day 0.
NCT00168298 measurement [clinicaltrials_resource:NCT00168298/measurement/02854263d9e475afe5bcd29d3957203a]NCT00168298 measurement [clinicaltrials_resource:NCT00168298/measurement/069439a81d6a48eae2a973aefe844a89]NCT00168298 measurement [clinicaltrials_resource:NCT00168298/measurement/32edbb8369f3ed1994934afddd8a2ddb]NCT00168298 measurement [clinicaltrials_resource:NCT00168298/measurement/434fc622a3baae667d5aa03911d466a4]NCT00168298 measurement [clinicaltrials_resource:NCT00168298/measurement/448bb630be5855ab266cd4678bb4b5ff]NCT00168298 measurement [clinicaltrials_resource:NCT00168298/measurement/59a319cca752e9829aa05f58cc630120]NCT00168298 measurement [clinicaltrials_resource:NCT00168298/measurement/6241013ca285ef4b52bc1c5859c37259]NCT00168298 measurement [clinicaltrials_resource:NCT00168298/measurement/7d2bbcee5a47810437930c8a6774cd8a]NCT00168298 measurement [clinicaltrials_resource:NCT00168298/measurement/855b390e14fdb4aeb176e49427c146eb]NCT00168298 measurement [clinicaltrials_resource:NCT00168298/measurement/889dfb8529d0d4baacd863dbc2147378]NCT00168298 measurement [clinicaltrials_resource:NCT00168298/measurement/b7c88081a8c5522d3483d52f386db72d]NCT00168298 measurement [clinicaltrials_resource:NCT00168298/measurement/c3ebfe81993f7a058615189fdb2e49da]NCT00168298 measurement [clinicaltrials_resource:NCT00168298/measurement/c52d9bcb8614b71cb3ce45fcc4f7a4d3]NCT00168298 measurement [clinicaltrials_resource:NCT00168298/measurement/d1e5d0545e78e66bcca5017e3d4c917d]NCT00168298 measurement [clinicaltrials_resource:NCT00168298/measurement/d73c905720e4349c928cdd6266c15e0d]
group id [clinicaltrials_vocabulary:group-id]
350 µg Dexamethasone [clinicaltrials_resource:NCT00168298/group/O2]
350 µg Dexamethasone intravitreal implant administered on Day 0.
Bio2RDF identifier
NCT00168298/group/O2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00168298/group/O2
group id [clinicaltrials_vocabulary:group-id]
description
350 µg Dexamethasone intravitreal implant administered on Day 0.
@en
identifier
clinicaltrials_resource:NCT00168298/group/O2
title
350 µg Dexamethasone
@en
type
label
350 µg Dexamethasone [clinicaltrials_resource:NCT00168298/group/O2]
@en